ZNANJE, STAVOVI I PONAŠANJE STUDENATA VISOKE ZDRAVSTVENE ŠKOLE U BEOGRADU O ZNAČAJU HPV INFEKCIJE, HPV VAKCINE I DRUGIH PREVENTIVNIH MERA
Sažetak
Uvod/Cilj: Znanje i informisanost o važnosti HPV vakcine protiv humanog papiloma virusa (HPV) u velikoj meri mogu doprineti redukciji obolevanja od raka grlića materice i drugih malignih tumora. Cilj ove studije je da se procene znanje, stavovi i ponašanja studenata o HPV infekciji i vakcini, kao i da se predlože mere za bolji obuhvat mladih HPV vakcinom.
Metode: Studijom preseka obuhvaćeno je 449 studenta zdravstene nege Visoke zdravstvene škole u Beogradu u periodu mart/maj 2019. godine. Upitnikom su prikupljeni podaci. U statističkoj analizi podataka korišćen je hi kvadrat test i Fišerov egzakni test.
Rezultati: Prosečna starost studenata iznosila je 21,02 ± 2,59 godine. Svoje znanje o HPV vakcini 86,0% studenata je ocenilo kao zadovoljavajuće. Na znanje o HPV vakcini u najvećem procentu su uticali nastavnici (79,7%), a zatim elektronski mediji (10,7%). Medicinske platforme za informisanje o HPV vakcini koristilo je samo 9% studenata. Prve informacije i određen stepen znanja o HPV infekciji i HPV vakcini studenti su usvojili u srednjoj školi (80,4% i 65,6%). Samo 3,4% studenata smatra da su mladi u Srbiji dovoljno informisani o HPV infekciji, a 0,4% o HPV vakcini. Svaki drugi student smatra da je jedan od načina za bolju informisanost mladih vršnjačka edukacija u školama. Oko 94% studenata zna da u našoj zemlji postoji organizovani skrining za rak grlića materice. Samo 10,2% studenata je želelo da vakciniše svoje dete HPV vakcinom, a oni koji to ne bi učinili kao glavni argument navode nedovoljnu informisanost o bezbednosti i efikasnosti vakcine (81,6%). Osobe koje su bile za HPV vakcinu su se značajno ređe podvrgavale redovnim ginekološkim pregledima.
Zaključak: Studenti Visoke zdravstvene škole u Beogradu smatraju da treba da postoji bolja edukacija o HPV infekciji i vakcini, što bi najbolje moglo da se realizuje sprovođenjem vršnjačke edukacije.
Reference
1. Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, et al. Global and Regional Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2016 Based on Systematic Review and Global Reporting. WHO Bulletin 2019;10(12): e0143304.
2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394-424. doi: 10.3322/caac.21492
3. Bray F, Soerjomataram I. The Changing Global Burden of Cancer: Transitions in Human Development and Implications for Cancer Prevention and Control. In: Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Cancer: Disease Control Priorities. Third Edition (Volume 3). Washington (DC): The International Bank for Reconstruction and Development/ The World Bank; 2015. pp.23-44.
4. WHO. Cancer prevention and control in the context of an integrated approach: report by the Secretariat. Geneva: World Health Organization, 2016.
5. Bruni L, Diaz M, Barrionuevo-Rosas L, Herrero R, Bray F, Bosch FX, et al. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health 2016; 4(7): e453-63. doi: 10.1016/S2214-109X(16)30099-7
6. Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, Sundström K, Dillner J, Sparén P. HPV Vaccination and the Risk of Invasive Cervical Cancer. N Engl J Med 2020; 383(14):1340-1348. doi: 10.1056/NEJMoa1917338.
7. Antić LJ, Antić D, Aleksopulos H, Despotović M, Zlatanović M. Znanja i stavovi studenata o humanom papiloma virusu i HPV vakcini. Sestirnska reč 2018; 21(77):4-9. doi: 10.5937/SestRec1877004A
8. Fu CJ, Pan XF, Zhao ZM, Saheb-Kashaf M, Chen F, Wen Y, et al. Knowledge, perceptions and acceptability of HPV vaccination among medical students in Chongqing, China Asian Pac J Cancer Prev 2014; 15(15):6187-93. doi: 10.7314/apjcp.2014.15.15.6187
9. Gottvall M, Tydén T, Höglund AT, Larsson M. Knowledge of human papillomavirus among high school students can be increased by an educational intervention. Int J STD AIDS 2010; 21:558–562. doi: 10.1258/ijsa.2010.010063.
10. Oh J-K, Lim MK, Yun EH, Lee E-H, Shin H-R. Awareness of and attitude towards human papillomavirus infection and vaccination for cervical cancer prevention among adult males and females in Korea: a nationwide interview survey. Vaccine 2010; 28:1854–1860. doi: 10.1016/j. vaccine.2009.11.079
11. Uzunlar Ö, Özyer Ş, Başer E, Toğrul C, Karaca M, Güngör T. A survey on human papillomavirus awareness and acceptance of vaccination among nursing students in a tertiary hospital in Ankara, Turkey. Vaccine 2013; 31(17):2191-5. doi: 10.1016/j.vaccine.2013.01.033.
12. Tonguc E, Gungor T, Var T, Kavak E, Yucel M, Uzunlar O. Knowledge about HPV, relation between HPV and cervix cancer and acceptability of HPV vaccine in women in eastern region of Turkey. J Gynecol Oncol 2013; 24:7–13. doi: 10.3802/jgo.2013.24.1.7
13. Thomas T, Dalmida S, Higgins M. The Student Human Papillomavirus Survey: Nurse-Led Instrument Development and Psychometric Testing to Increase Human Papillomavirus Vaccine Series Completion in Young Adults. J Nurs Meas 2016; 24(2):226-44. doi: 10.1891/1061-3749.24.2.226
14. López N, Garcés-Sánchez M, Panizo MB, de la Cueva IS, Artés MT, Ramos B, Cotarelo M. HPV knowledge and vaccine acceptance among European adolescents and their parents: a systematic literature review. Public Health Rev 2020; 41:10.doi: 10.1186/s40985-020-00126-5
15. Rožek Mitrović T. Petrović V. Višnjevac D. Seksualno ponašanje i uticaj na reproduktivno zdravlje adolescenata na teritoriji opštine Inđija. Prev Ped 2016;2(1-2):37-44. doi: 10.2298/MPNS0404116M
16. Monteiro DLM, Brollo LCS, de Souza TP, dos Santos JRP, Santos GR, Tatiane Correa T, et al. Knowledge on the HPV vaccine among university students, journal of the SAO PAULA, institute of tropical medicine. Rev Inst Med Trop São Paulo 2018; 60:e46. doi: 10.1590/S1678- 9946201860046
17. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356:1915–27. doi: 10.1056/ NEJMoa061741.
18. Klein NP, Hansen J, Chao C, et al. Safety of quadrivalent human papillomavirus vaccine administered routinely to females. Arch Pediatr Adolesc Med 2012; 166:1140–8. doi: 10.1001/archpediatrics.2012.1451.
19. Pruski D, Łagiedo-Żelazowska M, Millert-Kalińska S, Sikora J, Jach R, Przybylski M. Immunity after HPV Vaccination in Patients after Sexual Initiation. Vaccines (Basel) 2022; 10(5):728. doi: 10.3390/vaccines10050728
20. Di Mario S, Basevi V, Lopalco PL, Balduzzi S, D'Amico R, Magrini N. Corrigendum to "Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV". J Immunol Res 2017; 2017:4583487. doi: 10.1155/2017/4583487
21. Varricchio F, Iskander J, Destefano F, Ball R, Pless R, Braun MM, Chen RT. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 2004; 23(4):287-94. doi: 10.1097/00006454- 200404000-00002.
22. Wharton M. Vaccine safety: current systems and recent findings. Curr Opin Pediatr 2010; 22(1):88-93. doi: 10.1097/MOP.0b013e3283350425.
23. Dyda A, Shah Z, Surian D, Martin P, Coiera E, Dey A, Leask J, Dunn AG. HPV vaccine coverage in Australia and associations with HPV vaccine information exposure among Australian Twitter users. Hum Vaccin Immunother 2019; 15(7-8):1488-1495. doi: 10.1080/21645515.2019.1596712.
24. Newman PA, Logie CH, Lacombe-Duncan A, Baiden P, Tepjan S, Rubincam C, et al. Parents’ uptake of human papillomavirus vaccines for their children: a systematic review and meta-analysis of observational studies. BMJ Open 2018; 8(4): e019206. doi: 10.1136/ bmjopen-2017-019206
25. WHO Report, Equitable access to cervical cancer prevention in the WHO European Region increases as 4 more countries introduce HPV vaccination. Accessed: 27.11.2022. Available at: https://www.who. int/europe/news/item/16-11-2022-equitable-access-to-cervical-cancer-prevention-in-the-who-european-region-increases-as-4-more-countries-introduce-hpv-vaccination
26. Rulebook on immunization and protection with drugs. Official Gazette RS, br. 88/2017, 11/2018, 14/2018, 45/2018, 48/2018, 58/2018, 104/2018, 6/2021, 52/2021 i 66/2022.
27. Rulebook on the program of mandatory and recommended immunization of the population against specific infectious diseases. Official Gazette RS, br. 65/2020.
28. Institute of Public Health of Serbia „Dr Milan Jovanovic Batut”. Professional-methodological guidelines for mandatory recommended immunization of the population for 2021. Belgrade: Institute of Public Health of Serbia „Dr Milan Jovanovic Batut”, 2021.